Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: A prospective randomized study

Journal of Thoracic and Cardiovascular Surgery

Volumn 121, Issue 4, 2001, Pages 689-696

  Ascione, Raimondo ^a   Williams, Simon ^a   Lloyd, Clinton T ^a   Sundaramoorthi, Thiagarajamirthy ^a   Pitsis, Antonis A ^a   Angelini, Gianni D ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HEALTH CARE COST; HEART BEAT; HEART MUSCLE REVASCULARIZATION; HEMATOLOGY; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STERNOTOMY; THROMBOCYTE TRANSFUSION; TUBE;

EID: 0035323926     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2001.112823     Document Type: Article

References (28)

1. Kawahito K, Kobayashi E, Iwasa H, Misawa Y, Fuse K. Platelet aggregation during cardiopulmonary bypass evaluated by a laser light-scattering method. Ann Thorac Surg 1999;67:79-84.
2. Consten ECJ, Henny CP, Eijsman L, Dongelmans DA, van Oers MHJ. The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified. J Thorac Cardiovasc Surg 1996;112:162-7.
3. Asimakopoulos G, Taylor KM. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg 1998;66:2135-44.
4. Liu B, Belboul A, Larsson S, Roberts D. Factors influencing haemostasis and blood transfusion in cardiac surgery. Perfusion 1996;11:131-43.
5. Holloway DS, Summaria L, Sandesara J, Vagher JP, Alexander JC, Caprini JA. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988;59:62-7.
6. Birkmeyer JD, AuBuchon JP, Littenberg B, et al. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg 1994;57:161-9.
7. Bouchard D, Cartier R. Off-pump revascularization of multivessel coronary artery disease has a decreased myocardial infarction rate. Eur J Cardiothorac Surg 1998:14(Suppl 1):S20-4.
8. Ascione R, Lloyd CT, Gomes WJ, Caputo M, Bryan AJ, Angelini GD. Beating versus arrested heart revascularization: Evaluation of myocardial function in a prospective randomised study. Eur J Cardiothorac Surg 1999;15:685-90.
9. Ascione R, Lloyd CT, Underwood MJ, Gomes WJ, GD Angelini. On pump versus off pump coronary revascularization: Evaluation of renal function. Ann Thorac Surg 1999;68:493-8.
10. Brasil LA, Gomes WJ, Salomao R, Buffalo E. Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 1998;66:56-9.
11. Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Economic outcome of off pump coronary artery bypass surgery in a prospective randomised study. Ann Thorac Surg 1999;68:2237-42.
12. Caputo M, Dihmis W, Bryan AJ, Suleiman MS, Angelini GD. The effect of magnesium on myocardial metabolism during ischemia and reperfusion, in patients undergoing coronary artery surgery using intermittent antegrade warm blood cardioplegia. Eur J Cardiothorac Surg 1998;14:596-601.
13. Pitsis AA, Angelini GD. Off-pump coronary bypass grafting of the circumflex artery. Eur J Cardiothorac Surg 1999;16:478-9.
14. Brown HK, Kempton RA. The application of REML in clinical trials. Stat Med 1994;13:1601-17.
15. Despotis GJ, Joist JH, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: Impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997;43:1684-96.
16. Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993;82:107-17.
17. Khuri SF, Valeri CR, Loscalzo J, et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 1995;60:1008-14.
18. Baufreton C, Jansen PG, Le Besnerais P, et al. Heparin coating with aprotinin reduces blood activation during coronary artery operations. Ann Thorac Surg 1997;63:50-6.
19. Karski JM, Teasdale SJ, Norman P, et al. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial. J Thorac Cardiovasc Surg 1995;110:835-42.
20. Poirier NC, Carrier M, Lesperance J, et al. Quantitative angiographic assessment of coronary anastomoses performed without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999;117:292-7.
21. Lemmer JH, Dilling EW, Morton JR, et al. Aprotinin for primary coronary artery bypass grafting: A multicenter trial of three dose regimens. Ann Thorac Surg 1996;62:1659-67.
22. Despotis GJ, Filos KS, Zoys TN, Hogue CW Jr, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients. Anesth Analg 1996;82:13-21.
23. Weerasinghe A, Taylor KM. The platelet in cardiopulmonary bypass. Ann Thorac Surg 1998;66:2145-52.
24. Oberman HA. Indications and monitoring of use of fresh frozen plasma as a haemostatic agent. Curr Stud Hematol Blood Transfus 1986;53:125-32.
25. Spiess BD. The contribution of fibrinolysis to post bypass bleeding. J Cardiothorac Vasc Anesth 1991;5:13-7.
26. Zacharias A, Habib RH. Factors predisposing to median sternotomy complications. Deep vs superficial infections. Chest 1996;110:1173-8.
27. Moor AC, Dubbelman TM, Van Steveninck J, Braud A. Transfusion-transmitted diseases: Risks, prevention and perspectives. Eur J Haematol 1999;62:1-18.
28. Goodnough LT, Johnston MFM, Toy PTCY, et al. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991;265:86-90.